These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35166948)

  • 1. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy.
    Abdel-Nabey M; Chaba A; Serre J; Lengliné E; Azoulay E; Darmon M; Zafrani L
    Ann Intensive Care; 2022 Feb; 12(1):15. PubMed ID: 35166948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
    Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
    Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies.
    Anderson A; Shoulders L; James V; Ashcraft E; Cheng C; Ribeiro R; Elbahlawan L
    Front Oncol; 2023; 13():1234677. PubMed ID: 37664024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma.
    Personett HA; Barreto EF; McCullough KB; Dierkhising R; Leung N; Habermann TM
    Leuk Lymphoma; 2019 Sep; 60(9):2271-2277. PubMed ID: 31223041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
    Alakel N; Middeke JM; Schetelig J; Bornhäuser M
    Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
    Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
    Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?
    Canet E; Cheminant M; Zafrani L; Thieblemont C; Galicier L; Lengline E; Schnell D; Reuter D; Darmon M; Schlemmer B; Azoulay E
    Leuk Lymphoma; 2014 Oct; 55(10):2362-7. PubMed ID: 24325633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
    Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
    Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rasburicase for the management of tumor lysis syndrome in neonates.
    McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
    Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
    Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
    J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
    [No Abstract]   [Full Text] [Related]  

  • 12. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Interventions to Prevent Tumour Lysis Syndrome in Hematologic Malignancy: A Multisite Retrospective Chart Review.
    McKenna S; Cheung A; Wolfe A; Coleman BL; Detsky ME; Munshi L; Maze D; Burry L
    Can J Hosp Pharm; 2019; 72(6):435-445. PubMed ID: 31853144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.
    Dinnel J; Moore BL; Skiver BM; Bose P
    Core Evid; 2015; 10():23-38. PubMed ID: 25610345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options.
    Kikuchi S; Muro M; Kamihara Y; Wada A; Murakami J; Nabe Y; Minemura T; Sato T
    Int Cancer Conf J; 2023 Jan; 12(1):69-74. PubMed ID: 36605847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid overload and acute kidney injury in children with tumor lysis syndrome.
    Flood K; Rozmus J; Skippen P; Matsell DG; Mammen C
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29255. PubMed ID: 34302706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies.
    Yaman S; Başcı S; Turan G; Ulu BU; Yiğenoğlu TN; Dal MS; Kızıl Çakar M; Altuntaş F
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e71-e76. PubMed ID: 34565690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
    Bose P; Qubaiah O
    J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous Tumor Lysis Syndrome in Blastoid-Variant Mantle Cell Lymphoma: Considerations for the General Internist.
    Patel V; Case R
    J Investig Med High Impact Case Rep; 2020; 8():2324709620944709. PubMed ID: 32720820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-Dose Recombinant Urate Oxidase in the Treatment of Paediatric Tumour Lysis Syndrome: A Regional Cancer Centre Experience.
    L A; Reddy JM; Chebbi PG; Kumar N; Ar AK; M P; B S AK
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3897-3901. PubMed ID: 34967569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.